SCHEMBL22835191

SCHEMBL22835191

Clc1ccn2nc[c]c2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22835025 0.76
SCHEMBL19029766 0.76 PIM1 (0.33)
SCHEMBL22835139 0.72
SCHEMBL22834893 0.72
SCHEMBL8104798 0.63
SCHEMBL25157822 0.59 PIK3CA (0.43)
SCHEMBL19102376 0.59 FLT3 (0.39)
SCHEMBL3037759 0.59 FLT3 (0.39)
SCHEMBL17759350 0.56 FLT3 (0.44)
SCHEMBL15951841 0.56 CDK2 (0.51)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112979654-B Heteroaryl fused ring compounds, preparation method and application thereof 赛诺哈勃药业(成都)有限公司 2024-03-19 CN disclosed
US-20230087118-A1 IMIDAZO[1,2-a]PYRIDINYL DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE BIOGEN MA INC. 2023-03-23 US disclosed
EP-3990454-A1 IMIDAZO[1,2-A]PYRIDINYL DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE Biogen MA Inc. (US) 2022-05-04 EP disclosed
CN-112979654-A Heteroaryl fused ring compound, preparation method and application thereof 成都倍特药业有限公司 2021-06-18 CN disclosed
WO-2020263980-A1 IMIDAZO[1,2-A]PYRIDINYL DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE BIOGEN MA INC. (US) 2020-12-30 WO disclosed